Main Article Content
Abstract
Keywords
Article Details
Copyright (c) 2019 Folia Medica Indonesiana
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
-
Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
You are free to :
Share ” copy and redistribute the material in any medium or format.
Adapt ” remix, transform, and build upon the material.
References
- Adrian TBR, Montiel JL, Fernandez G, Valecillo A (2015). Role of cytokines and other factors involved in the Mycobacterium tuberculosis infection.. World Journal of Immunology 5, 16-50
- Antonio, Lemoa CM, Matos ED (2013). Multidrug-resistant tuberculosis, Spesial article. The Brazilian Journal of Infections Disease 7, 239-246
- Baker MA, et al (2011). The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Medicine 9, 1-15
- Cavalcanti YVN, Brelaz MCA, Neves JKAL, Ferraz JC, Pereira VRA (2012). Review article: Role of TNF-Alpha, IFN-Gamma, and IL-10 in the development of pulmonary tuberculosis. Pulmonary Medicine 2012, 1-10
- Clifford V, et al (2015). Cytokines for monitoring anti-tuberculous therapy: A systematic review. Elsevier XXX, 1-12
- Goldsack L, Kirman JR (2007). Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. Tuberculosis (Edinb) 87, 465-73
- Holtz TH, et al (2006). Time to sputum culture conversion in MDR-TB: Predictor and relationship to treatment ountcome. Annal of Internal Medicine 144, 650-660
- Jain SL, et al (2008). Antibiotic treatment of tuberculosis: Old problems. Microbe 3, 285
- Khan A, et al 2016. Interferon-Gamma improves macrophages function againts M. Tuberculosis in multidrug-resistant tuberculosis patients. Hindawi 1-10, 2016.
- Kinjo Y, et al (2002). Contribution ol IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: A comparative study with IL-12p40. The Journal of Immunolog 169, 323-329
- Mase S, Chorba T, Lobue P, Castro K (2013). Provisional CDC guidlines for the use and safety monitoring of bedaquline fumarate (Sirturo) for MDR TB. MMWR 62, 1
- Mihardja L, Lolong BD, Ghani L (2015). Prevalensi diabetes melitus pada tuberkulosis dan masalah terapi. Jurnal Ekologi Kesehatan 14, 350-358
- Reviono, et al 2014. Multidrug resistant tuberculosis (MDR-TB): Tinjauan epidemiologi dan faktor risiko efek samping obat anti tuberkulosis. MKB 46, 189-196
- Shin S, et al (2007). Adverse reactions among patients being trated for MDT-TBin Tomsk, Russia. Int J Tuberc Lung Dis 11, 1314-1320
References
Adrian TBR, Montiel JL, Fernandez G, Valecillo A (2015). Role of cytokines and other factors involved in the Mycobacterium tuberculosis infection.. World Journal of Immunology 5, 16-50
Antonio, Lemoa CM, Matos ED (2013). Multidrug-resistant tuberculosis, Spesial article. The Brazilian Journal of Infections Disease 7, 239-246
Baker MA, et al (2011). The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Medicine 9, 1-15
Cavalcanti YVN, Brelaz MCA, Neves JKAL, Ferraz JC, Pereira VRA (2012). Review article: Role of TNF-Alpha, IFN-Gamma, and IL-10 in the development of pulmonary tuberculosis. Pulmonary Medicine 2012, 1-10
Clifford V, et al (2015). Cytokines for monitoring anti-tuberculous therapy: A systematic review. Elsevier XXX, 1-12
Goldsack L, Kirman JR (2007). Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. Tuberculosis (Edinb) 87, 465-73
Holtz TH, et al (2006). Time to sputum culture conversion in MDR-TB: Predictor and relationship to treatment ountcome. Annal of Internal Medicine 144, 650-660
Jain SL, et al (2008). Antibiotic treatment of tuberculosis: Old problems. Microbe 3, 285
Khan A, et al 2016. Interferon-Gamma improves macrophages function againts M. Tuberculosis in multidrug-resistant tuberculosis patients. Hindawi 1-10, 2016.
Kinjo Y, et al (2002). Contribution ol IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: A comparative study with IL-12p40. The Journal of Immunolog 169, 323-329
Mase S, Chorba T, Lobue P, Castro K (2013). Provisional CDC guidlines for the use and safety monitoring of bedaquline fumarate (Sirturo) for MDR TB. MMWR 62, 1
Mihardja L, Lolong BD, Ghani L (2015). Prevalensi diabetes melitus pada tuberkulosis dan masalah terapi. Jurnal Ekologi Kesehatan 14, 350-358
Reviono, et al 2014. Multidrug resistant tuberculosis (MDR-TB): Tinjauan epidemiologi dan faktor risiko efek samping obat anti tuberkulosis. MKB 46, 189-196
Shin S, et al (2007). Adverse reactions among patients being trated for MDT-TBin Tomsk, Russia. Int J Tuberc Lung Dis 11, 1314-1320